BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16698578)

  • 21. Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment.
    Huet PM; Vincent C; Deslaurier J; Coté J; Matsutami S; Boileau R; Huet-van Kerckvoorde J
    Gastroenterology; 2008 Nov; 135(5):1552-60. PubMed ID: 18722374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
    Okonko DO; Grzeslo A; Witkowski T; Mandal AK; Slater RM; Roughton M; Foldes G; Thum T; Majda J; Banasiak W; Missouris CG; Poole-Wilson PA; Anker SD; Ponikowski P
    J Am Coll Cardiol; 2008 Jan; 51(2):103-12. PubMed ID: 18191732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and laboratory predictors of esophageal varices in children and adolescents with portal hypertension syndrome.
    Fagundes ED; Ferreira AR; Roquete ML; Penna FJ; Goulart EM; Figueiredo Filho PP; Bittencourt PF; Carvalho SD; Albuquerque W
    J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):178-83. PubMed ID: 18223377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure.
    Laleman W; Wilmer A; Evenepoel P; Elst IV; Zeegers M; Zaman Z; Verslype C; Fevery J; Nevens F
    Crit Care; 2006; 10(4):R108. PubMed ID: 16859530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A clinical study on splanchnic hemodynamic changes after orthotopic liver transplantation for patients with portal hypertension].
    Jiang SM; Zhou GW; Shen C; Yan JQ; Wan L; Li QY; Yang WP; Shen BY; Chen H; Peng CH; Li HW
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(22):1699-702. PubMed ID: 19094727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The characteristics of respiratory function and pulmonary hemodynamics in patients with portal hypertension.
    Sun YW; Hua R; Huo YM; Cao H; Wu ZY; Luo M; Xu Q; Chen W; Kong XM
    J Dig Dis; 2012 Feb; 13(2):75-81. PubMed ID: 22257475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged Q-T(c) interval in mild portal hypertensive cirrhosis.
    Ytting H; Henriksen JH; Fuglsang S; Bendtsen F; Møller S
    J Hepatol; 2005 Oct; 43(4):637-44. PubMed ID: 16083986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Previous portal hypertension surgery negatively affects results of mesenteric to left portal vein bypass.
    Chin AC; Thow F; Superina RA
    J Pediatr Surg; 2008 Jan; 43(1):114-9; discussion 119. PubMed ID: 18206467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D
    Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemoglobin and N-terminal pro-brain natriuretic peptide: Independent and synergistic predictors of mortality in patients with acute heart failure Results from the International Collaborative of NT-proBNP (ICON) Study.
    Baggish AL; van Kimmenade R; Bayes-Genis A; Davis M; Lainchbury JG; Frampton C; Pinto Y; Richards MA; Januzzi JL
    Clin Chim Acta; 2007 Jun; 381(2):145-50. PubMed ID: 17445789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.
    Ishizawa T; Hasegawa K; Aoki T; Takahashi M; Inoue Y; Sano K; Imamura H; Sugawara Y; Kokudo N; Makuuchi M
    Gastroenterology; 2008 Jun; 134(7):1908-16. PubMed ID: 18549877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined splenocaval or mesocaval C shunt and portoazygous devascularization in the treatment of portal hypertension: analysis of 150 cases.
    Feng LS; Chen XP
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):70-3. PubMed ID: 16481287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis.
    Nagula S; Jain D; Groszmann RJ; Garcia-Tsao G
    J Hepatol; 2006 Jan; 44(1):111-7. PubMed ID: 16274836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperdynamic circulation in prehepatic portal hypertension: role of tumor necrosis factor-alpha.
    Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Wu SL; Tai CC; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Mar; 59(3):145-50. PubMed ID: 9198288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The MELD score in advanced liver disease: association with clinical portal hypertension and mortality.
    Saab S; Landaverde C; Ibrahim AB; Durazo F; Han S; Yersiz H; Farmer DG; Ghobrial RM; Goldstein LI; Tong MJ; Busuttil RW
    Exp Clin Transplant; 2006 Jun; 4(1):395-9. PubMed ID: 16827633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative hemoglobin level as a predictor of survival after coronary artery bypass grafting: a comparison with the matched general population.
    van Straten AH; Hamad MA; van Zundert AJ; Martens EJ; Schönberger JP; de Wolf AM
    Circulation; 2009 Jul; 120(2):118-25. PubMed ID: 19564556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Function of portal pressure during operation on the choice of surgical approaches in portal hypertension].
    Chen W; Luo M; Sun YW; Xu Q; Zhao G; Hua R; Liu W; Jiang CH; Shi CY; Wu ZY
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(22):1703-6. PubMed ID: 19094728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partial splenectomy for portal hypertension in cystic fibrosis related liver disease.
    Louis D; Duc ML; Reix P; Chazalette JP; Durieu I; Feigelson J; Bellon G
    Pediatr Pulmonol; 2007 Dec; 42(12):1173-80. PubMed ID: 17968998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.